You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Immune-checkpoint inhibitors for glioblastoma: what have we learned?
|
|---|---|
| Published in |
Arquivos de Neuro-Psiquiatria, May 2022
|
| DOI | 10.1590/0004-282x-anp-2022-s129 |
| Pubmed ID | |
| Authors |
Antonio Omuro |
Mendeley readers
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 23 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 4 | 17% |
| Student > Ph. D. Student | 1 | 4% |
| Student > Postgraduate | 1 | 4% |
| Unknown | 17 | 74% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 4 | 17% |
| Arts and Humanities | 1 | 4% |
| Immunology and Microbiology | 1 | 4% |
| Biochemistry, Genetics and Molecular Biology | 1 | 4% |
| Unknown | 16 | 70% |